270 related articles for article (PubMed ID: 21781149)
21. Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension.
Pouleur AC; Uno H; Prescott MF; Desai A; Appelbaum E; Lukashevich V; Smith BA; Dahlöf B; Solomon SD;
J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):483-90. PubMed ID: 21746765
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
[TBL] [Abstract][Full Text] [Related]
23. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection.
Peng F; Lin J; Lin L; Tang H
Int J Mol Med; 2012 Dec; 30(6):1376-86. PubMed ID: 23064712
[TBL] [Abstract][Full Text] [Related]
24. Effect of losartan and amlodipine on left ventricular diastolic function in patients with mild-to-moderate hypertension (J-ELAN): rationale and design.
J-ELAN Investigators
Circ J; 2006 Jan; 70(1):124-8. PubMed ID: 16377936
[TBL] [Abstract][Full Text] [Related]
25. The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension.
Watanabe S; Okura T; Kurata M; Irita J; Manabe S; Miyoshi K; Fukuoka T; Murakami K; Higaki J
Clin Ther; 2006 Oct; 28(10):1677-85. PubMed ID: 17157123
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of losartan in children with Alport syndrome--results from a subgroup analysis of a prospective, randomized, placebo- or amlodipine-controlled trial.
Webb NJ; Lam C; Shahinfar S; Strehlau J; Wells TG; Gleim GW; Le Bailly De Tilleghem C
Nephrol Dial Transplant; 2011 Aug; 26(8):2521-6. PubMed ID: 21285125
[TBL] [Abstract][Full Text] [Related]
27. [The effectiveness and tolerability of losartan and effect on left ventricular mass in patients with essential hypertension].
Tedesco MA; Ratti G; Aquino D; Caccavale A; Acitorio M; Rocereto A; Cosimi R; Coppolino P; Iarussi D; Iacono A
Cardiologia; 1998 Jan; 43(1):53-9. PubMed ID: 9534293
[TBL] [Abstract][Full Text] [Related]
28. Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus.
Fogari R; Zoppi A; Maffioli P; Monti C; Lazzari P; Mugellini A; Derosa G
Diabetes Obes Metab; 2012 Apr; 14(4):341-7. PubMed ID: 22074122
[TBL] [Abstract][Full Text] [Related]
29. Echocardiographic changes and treatment goal rates after a 6-month combined treatment with amlodipine and losartan: a validation study in Andean countries (METAL study).
Pérez Carreño JG; Romero JD; Villar Centeno JC;
Ther Adv Cardiovasc Dis; 2013 Oct; 7(5):237-45. PubMed ID: 24096616
[TBL] [Abstract][Full Text] [Related]
30. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
[TBL] [Abstract][Full Text] [Related]
31. Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.
Wachtell K; Bella JN; Rokkedal J; Palmieri V; Papademetriou V; Dahlöf B; Aalto T; Gerdts E; Devereux RB
Circulation; 2002 Mar; 105(9):1071-6. PubMed ID: 11877357
[TBL] [Abstract][Full Text] [Related]
32. Effects of losartan and amlodipine on urinary albumin excretion and ambulatory blood pressure in hypertensive type 2 diabetic patients with overt nephropathy.
Yasuda G; Ando D; Hirawa N; Umemura S; Tochikubo O
Diabetes Care; 2005 Aug; 28(8):1862-8. PubMed ID: 16043724
[TBL] [Abstract][Full Text] [Related]
33. Two-year follow-up study to evaluate the reduction of left ventricular mass and diastolic function in mild to moderate diastolic hypertensive patients.
Beltman F; Heesen W; Smit A; May J; de Graeff P; Havinga T; Schuurman F; van der Veur E; Lie K; Meyboom-de Jong B
J Hypertens Suppl; 1998 Oct; 16(6):S15-9. PubMed ID: 9856379
[TBL] [Abstract][Full Text] [Related]
34. Effects of losartan titrated to Losartan/Hydrochlorothiazide and amlodipine on left ventricular mass in patients with mild-to-moderate hypertension. A double-blind randomized controlled study.
Martina B; Dieterle T; Weinbacher M; Battegay E
Cardiology; 1999; 92(2):110-4. PubMed ID: 10702653
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the effects of amlodipine and losartan on blood pressure and diurnal variation in hypertensive stroke patients: a prospective, randomized, double-blind, comparative parallel study.
Kwon HM; Shin JW; Lim JS; Hong YH; Lee YS; Nam H
Clin Ther; 2013 Dec; 35(12):1975-82. PubMed ID: 24296324
[TBL] [Abstract][Full Text] [Related]
36. Association of hemoglobin delivery with left ventricular structure and function in hypertensive patients: Losartan Intervention for End Point Reduction in Hypertension Study.
Narayan P; Papademetriou V; Wachtell K; Gerdts E; Boman K; Nieminen MS; de Simone G; Dahlöf B; Fyhrquist F; Hoieggen A; Devereux RB
Hypertension; 2006 May; 47(5):868-73. PubMed ID: 16567586
[TBL] [Abstract][Full Text] [Related]
37. Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension.
Takami T; Shigematsu M
Clin Exp Hypertens; 2003 Nov; 25(8):525-35. PubMed ID: 14649310
[TBL] [Abstract][Full Text] [Related]
38. Losartan improves regional left ventricular systolic and diastolic function in patients with hypertension: accurate evaluation using a newly developed color-coded tissue doppler imaging technique.
Tanaka H; Oki T; Tabata T; Yamada H; Harada K; Kimura E; Oishi Y; Ishimoto T; Ito S
J Card Fail; 2004 Oct; 10(5):412-20. PubMed ID: 15470652
[TBL] [Abstract][Full Text] [Related]
39. Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study.
Boman K; Gerdts E; Wachtell K; Dahlöf B; Nieminen MS; Olofsson M; Papademetriou V; Devereux RB
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):242-8. PubMed ID: 19369828
[TBL] [Abstract][Full Text] [Related]
40. Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia.
Ge CJ; Lu SZ; Chen YD; Wu XF; Hu SJ; Ji Y
Heart Vessels; 2008 Mar; 23(2):91-5. PubMed ID: 18389332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
